This grant from the National Cancer Institute (NCI) is designed to support the development and characterization of advanced biomimetic tissue-engineered technologies for innovative cancer research. It seeks collaborative, multidisciplinary projects that integrate regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology. The primary purpose is to generate novel experimental models that accurately mimic cancer pathophysiology, enabling testable cancer research hypotheses. Projects funded will contribute to the Cancer Tissue Engineering Collaborative (TEC) Research Program. This initiative aims to catalyze the advancement of well-characterized in vitro and ex vivo systems, expand their applicability across diverse cancer types, and promote deeper exploration of cancer phenomena through these sophisticated biomimetic systems. The goal is to significantly enhance our understanding and approach to cancer.
Opportunity ID: 337486
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-099 |
| Funding Opportunity Title: | Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 21, 2022 |
| Last Updated Date: | Nov 22, 2024 |
| Original Closing Date for Applications: | May 07, 2025 |
| Current Closing Date for Applications: | Nov 23, 2024 |
| Archive Date: | Dec 23, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $40,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis. The projects supported by this FOA will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program. The Cancer TEC Program will (1) catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research, (2) expand the breadth of these systems to several cancer types, and (3) promote the exploration of cancer phenomena with biomimetic tissue-engineered systems. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-22-099.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| updated close date | Nov 22, 2024 | |
| Jan 21, 2022 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-099 |
| Funding Opportunity Title: | Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 21, 2022 |
| Last Updated Date: | Nov 22, 2024 |
| Original Closing Date for Applications: | May 07, 2025 |
| Current Closing Date for Applications: | Nov 23, 2024 |
| Archive Date: | Dec 23, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $40,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis. The projects supported by this FOA will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program. The Cancer TEC Program will (1) catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research, (2) expand the breadth of these systems to several cancer types, and (3) promote the exploration of cancer phenomena with biomimetic tissue-engineered systems. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-22-099.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-099 |
| Funding Opportunity Title: | Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 21, 2022 |
| Last Updated Date: | Jan 21, 2022 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 07, 2025 |
| Archive Date: | Jun 12, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $40,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Small businesses Public and State controlled institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Special district governments Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis. The projects supported by this FOA will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program. The Cancer TEC Program will (1) catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research, (2) expand the breadth of these systems to several cancer types, and (3) promote the exploration of cancer phenomena with biomimetic tissue-engineered systems. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-22-099.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Related Documents
Folder 337486 Full Announcement-PAR-22-099 -> PAR-22-099-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00271453 | May 05, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277800 | Nov 01, 2022 | Nov 23, 2024 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288563 | Nov 07, 2024 | Nov 23, 2024 | View |
Package 1
Mandatory forms
337486 RR_SF424_5_0-5.0.pdf
337486 PHS398_CoverPageSupplement_5_0-5.0.pdf
337486 RR_OtherProjectInfo_1_4-1.4.pdf
337486 PerformanceSite_4_0-4.0.pdf
337486 RR_KeyPersonExpanded_4_0-4.0.pdf
337486 PHS398_ResearchPlan_4_0-4.0.pdf
337486 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337486 RR_Budget_3_0-3.0.pdf
337486 RR_SubawardBudget30_3_0-3.0.pdf
337486 PHS398_ModularBudget_1_2-1.2.pdf
337486 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
337486 RR_SF424_5_0-5.0.pdf
337486 PHS398_CoverPageSupplement_5_0-5.0.pdf
337486 RR_OtherProjectInfo_1_4-1.4.pdf
337486 PerformanceSite_4_0-4.0.pdf
337486 RR_KeyPersonExpanded_4_0-4.0.pdf
337486 PHS398_ResearchPlan_5_0-5.0.pdf
337486 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337486 RR_Budget_3_0-3.0.pdf
337486 RR_SubawardBudget30_3_0-3.0.pdf
337486 PHS398_ModularBudget_1_2-1.2.pdf
337486 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
337486 RR_SF424_5_0-5.0.pdf
337486 PHS398_CoverPageSupplement_5_0-5.0.pdf
337486 RR_OtherProjectInfo_1_4-1.4.pdf
337486 PerformanceSite_4_0-4.0.pdf
337486 RR_KeyPersonExpanded_4_0-4.0.pdf
337486 PHS398_ResearchPlan_5_0-5.0.pdf
337486 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337486 RR_Budget_3_0-3.0.pdf
337486 RR_SubawardBudget30_3_0-3.0.pdf
337486 PHS398_ModularBudget_1_2-1.2.pdf
337486 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
